In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.
As of close of business last night, Alignment Healthcare Inc’s stock clocked out at $15.67, up 1.36% from its previous closing price of $15.46. In other words, the price has increased by $1.36 from its previous closing price. On the day, 0.74 million shares were traded. ALHC stock price reached its highest trading level at $15.67 during the session, while it also had its lowest trading level at $15.18.
Ratios:
To gain a deeper understanding of ALHC’s stock, we examine its different ratios. In the meantime, Its Debt-to-Equity ratio is 1.92 whereas as Long-Term Debt/Eq ratio is at 1.91.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Stephens on December 03, 2024, Upgraded its rating to Overweight and sets its target price to $17 from $13 previously.
BofA Securities Upgraded its Neutral to Buy on May 30, 2024, whereas the target price for the stock was revised from $7.75 to $11.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Jan 24 ’25 when Kardes Hakan sold 14,500 shares for $14.98 per share. The transaction valued at 217,277 led to the insider holds 295,444 shares of the business.
Kardes Hakan sold 10,500 shares of ALHC for $157,370 on Jan 21 ’25. The Chief Experience Officer now owns 309,944 shares after completing the transaction at $14.99 per share. On Jan 21 ’25, another insider, HAKAN KARDES, who serves as the Officer of the company, bought 25,000 shares for $14.58 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ALHC now has a Market Capitalization of 3003876352 and an Enterprise Value of 2844168704. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.22 while its Price-to-Book (P/B) ratio in mrq is 26.21. Its current Enterprise Value per Revenue stands at 1.153 whereas that against EBITDA is -30.36.
Stock Price History:
The Beta on a monthly basis for ALHC is 1.51, which has changed by 1.317841 over the last 52 weeks, in comparison to a change of 0.208081 over the same period for the S&P500. Over the past 52 weeks, ALHC has reached a high of $15.82, while it has fallen to a 52-week low of $4.46. The 50-Day Moving Average of the stock is 23.52%, while the 200-Day Moving Average is calculated to be 55.18%.
Shares Statistics:
It appears that ALHC traded 2.01M shares on average per day over the past three months and 2096000 shares per day over the past ten days. A total of 191.60M shares are outstanding, with a floating share count of 92.47M. Insiders hold about 51.76% of the company’s shares, while institutions hold 42.91% stake in the company. Shares short for ALHC as of 1736899200 were 9277573 with a Short Ratio of 4.61, compared to 1734048000 on 9352640. Therefore, it implies a Short% of Shares Outstanding of 9277573 and a Short% of Float of 7.5600000000000005.
